Synjardy XR 25 mg/1

Synjardy XR 25 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to help manage type 2 diabetes by improving blood sugar control. This medication is suitable for adults and is available in a convenient pack size of 7 tablets per bottle.

Synjardy XR 25 mg/1 is primarily used for the management of type 2 diabetes in adults. It works by combining two active ingredients, empagliflozin and metformin hydrochloride, to help control blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People often ask, 'What is Synjardy XR used for?' and the answer is that it is designed to improve glycemic control in adults with type 2 diabetes.

Common effects of Synjardy XR 25 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals may also experience urinary tract infections or constipation. These effects can vary from person to person, and it is important to consult with a healthcare provider if any of these symptoms persist or worsen.

Synjardy XR 25 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Synjardy XR 25 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it can increase the risk of side effects.